A detailed history of Adar1 Capital Management, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 3,025,450 shares of ROIV stock, worth $36.2 Million. This represents 5.68% of its overall portfolio holdings.

Number of Shares
3,025,450
Previous 4,150,009 27.1%
Holding current value
$36.2 Million
Previous $43.9 Billion 20.41%
% of portfolio
5.68%
Previous 8.28%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.17 - $12.5 $11.4 Million - $14.1 Million
-1,124,559 Reduced 27.1%
3,025,450 $34.9 Billion
Q2 2024

Aug 13, 2024

BUY
$10.36 - $11.74 $14.1 Million - $15.9 Million
1,358,139 Added 48.65%
4,150,009 $43.9 Billion
Q1 2024

May 15, 2024

BUY
$9.87 - $11.8 $15.2 Million - $18.1 Million
1,535,279 Added 122.18%
2,791,870 $29.4 Billion
Q4 2023

Feb 14, 2024

BUY
$8.38 - $11.58 $10.5 Million - $14.6 Million
1,256,591 New
1,256,591 $14.1 Billion

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.43B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.